Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications.
Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications.
复制标题
糖尿病患者的白内障手术。
DOI：
--
复制
发表时间：
2002
影响因子：
3.4
通讯作者：
H. Lund‐Andersen
中科院分区：
文献类型：
--
作者：
P. Flesner;B. Sander;V. Henning;H. Parving;M. Dornonville de la Cour;H. Lund‐Andersen
目的
本研究旨在评估糖尿病患者的白内障手术。一名经验丰富的外科医生对所有受试者进行了超声乳化，并植入了相同的表面涂层一体式PMMA晶状体。然后评价透镜荧光和血-房水屏障（BAB）作为实验术前风险指标。
结果
在随访期间，39例糖尿病患者中有10例单侧进展为糖尿病视网膜病变或发生黄斑水肿，这是一个显著的相对风险。术后视网膜病变/黄斑水肿进展的患者组与无视网膜病变/黄斑水肿进展的患者组之间，透镜荧光、BAB、HbA 1c、视网膜病变水平、糖尿病类型/持续时间、糖尿病治疗或抗高血压治疗均无显著差异。结果表明，NIDDM（非胰岛素依赖型糖尿病/2型糖尿病）患者术后黄斑水肿的风险可能增加。
结论
当糖尿病视网膜病变（DR）不处于增殖期时，不应将其视为现代白内障手术的禁忌症。透镜荧光和BAB作为DR术后进展的风险指标均无价值。
PURPOSE
This study presents an evaluation of cataract surgery on diabetic patients. One experienced surgeon carried out phaco emulsification on all subjects and the same surface-coated one-piece PMMA-lens-type was implanted. The lens fluorescence and the blood-aqueous barrier (BAB) were then evaluated as experimental preoperative risk indicators.
RESULTS
During follow-up, 10 out of 39 diabetic patients progressed unilaterally in diabetic retinopathy or developed macular oedema, a significant relative risk. Neither lens fluorescence, BAB, HbA1c, level of retinopathy, type/duration of diabetes, diabetes treatment or antihypertensive treatment differed significantly between the group of patients with postoperative progression of retinopathy/macular oedema and those without. Results indicated NIDDM (non-insulin-dependent diabetes mellitus/type 2 diabetes) patients might have increased risk of a postoperative macular oedema.
CONCLUSION
When diabetic retinopathy (DR) is not in a proliferative phase it should not be regarded as a contraindication to modern cataract surgery. Neither lens fluorescence nor BAB is valuable as a risk indicator for postoperative progression of DR.
影响因子：
13.7
作者：
R. Klein;B. Klein;S. Moss;M. Davis;D. DeMets
通讯作者：
R. Klein;B. Klein;S. Moss;M. Davis;D. DeMets